Multiple receptors for neuropeptide Y in the hippocampus: Putative roles in seizures and cognition

Brain Research

Volumn 848, Issue 1-2, 1999, Pages 153-166

  Redrobe, John P ^a   Dumont, Yvan ^a   St Pierre, Jacques André ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cognition; Hippocampus; Neuropeptide Y; Seizure

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y3 RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BINDING SITE; COGNITION; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEARNING; MARMOSET; MEMORY; MONKEY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEIZURE; SPECIES DIFFERENCE;

EID: 0033457358     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02119-8     Document Type: Article

References (129)

1. Ammar D.A., Eadie D.M., Wong D.J., Ma Y.Y., Kolakowski L.F.J., Yang-Feng T.L., Thompson D.A. Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene. Genomics. 38:1996;392-398.
2. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17:1997;8927-8936.
3. 4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270:1995;26762-26765.
4. Beal M.F., Mazurek M.F., Chattha G.K., Svendsen C.N., Bird E.D., Martin J.B. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann. Neurol. 20:1986;282-288.
5. 5 receptors. Trends Pharmacol. Sci. 20:1999;104-106.
6. Blomqvist A.G., Herzog H. Y-receptor subtypes - how many more? Trends Neurosci. 20:1997;294-298.
7. 1 cDNA from Xenopus laevis. Biochim. Biophys. Acta. 1261:1995;439-441.
8. 5 receptor species homologs. Regul. Pept. 75:1998;45-53.
9. 5 receptor binding sites in two rat experimental models of epilepsy. Soc. Neurosci. Abstr. 25:1999;1350.
10. 2 receptor messenger RNA in the human post mortem brain. Neuroscience. 86:1998;167-178.
11. Cha C.I., Lee Y.I., Lee E.Y., Park K.H., Baik S.H. Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats. Brain Res. 753:1997;235-244.
12. Cha C.I., Lee Y.I., Park K.H., Baik S.H. Age-related change of neuropeptide Y-immunoreactive neurons in the cerebral cortex of aged rats. Neurosci. Lett. 214:1996;37-40.
13. Chan-Palay V., Yasargil G., Hamid Q., Polak J.M., Palay S.L. Simultaneous demonstrations of neuropeptide Y gene expression and peptide storage in single neurons of the human brain. Proc. Natl. Acad. Sci. USA. 85:1988;3213-3215.
14. Chan-Palay V., Kohler C., Haesler U., Lang W., Yasargil G. Distribution of neurons and axons immunoreactive with antisera against neuropeptide Y in the normal human hippocampus. J. Comp. Neurol. 248:1986;360-375.
15. Chan-Palay V., Lang W., Haesler U., Kohler C., Yasargil G. Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia. J. Comp. Neurol. 248:1986;376-394.
16. Chan-Palay V., Lang W., Allen Y.S., Haesler U., Polak J.M. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia. J. Comp. Neurol. 238:1985;390-400.
17. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience. 15:1985;1159-1181.
18. Clark J.T., Kalra P.S., Kalra S.P. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology. 117:1985;2435-2442.
19. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 115:1984;427-429.
20. Colmers W.F., Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 17:1994;373-379.
21. 5 receptor. J. Clin. Invest. 102:1998;2136-2145.
22. Danho W., Triscari J., Vincent G., Nakajima T., Taylor J., Kaiser E.T. Synthesis and biological evaluation of pNPY fragments. Int. J. Pept. Protein Res. 32:1988;496-505.
23. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience. 18:1986;545-618.
24. 2 receptor antagonist, Eur. J. Pharmacol., in press.
25. Doods H.N., Krause J. Different neuropeptide Y receptor subtypes in rat and rabbit vas deferens. Eur. J. Pharmacol. 204:1991;101-103.
26. Y. Dumont, D. Jacques, J.A. St-Pierre, Y. Tong, R. Parker, H. Herzog, R. Quirion, Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains, in: R. Quirion, T. Hokfelt, A. Bjorklund (Eds.), Handbook of Chemical Neuroanatomy, Elsevier Science, London, in press.
27. Y. Dumont, A. Cadieux, A. Fournier, H.N. Doods, R. Quirion, Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIBO3304 (Y1) and CGP71683A (Y5), Can. J. Physiol. Pharmacol., in press.
28. 2 receptor antagonist, Br. J. Pharmacol., submitted for publication.
29. 5 receptor subtype in the rat brain. J. Neurosci. 18:1998;5565-5574.
30. 5 receptors in rodents, guinea pig, and primates brains. J. Comp. Neurol. 402:1998;372-384.
31. Dumont Y., Fournier A., St-Pierre S., Quirion R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci. 13:1993;73-86.
32. Dumont Y., Martel J.C., Fournier A., St-Pierre S., Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol. 38:1992;125-167.
33. 2 receptors in the rat brain. Eur. J. Pharmacol. 191:1990;501-503.
34. Eva C., Oberto A., Sprengel R., Genazzani E. The murine NPY-1 receptor gene. Structure and delineation of tissue-specific expression. FEBS Lett. 314:1992;285-288.
35. Eva C., Keinanen K., Monyer H., Seeburg P., Sprengel R. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett. 271:1990;81-84.
36. Flood J.F., Morley J.E. Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation. Peptides. 10:1989;963-966.
37. Flood J.F., Baker M.L., Hernandez E.N., Morley J.E. Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain Res. 503:1989;73-82.
38. Flood J.F., Hernandez E.N., Morley J.E. Modulation of memory processing by neuropeptide Y. Brain Res. 421:1987;280-290.
39. 1 receptor agonist. Proc. Natl. Acad. Sci. USA. 87:1990;182-186.
40. 2 receptors. J. Biol. Chem. 265:1990;11706-11712.
41. 1 receptors. Eur. J. Neurosci. 10:1998;757-759.
42. Gehlert D.R. Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc. Soc. Exp. Biol. Med. 218:1998;7-22.
43. Gehlert D.R. Subtypes of receptors for neuropeptide Y: implications for the targeting of therapeutics. Life Sci. 55:1994;551-562.
44. 2 receptor. Mol. Pharmacol. 49:1996;224-228.
45. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
46. 2 receptor subtype. J. Biol. Chem. 270:1995;26758-26761.
47. 3-36 to neuropeptide Y receptor subtypes in rat forebrain J. Neurochem. 72:1999;1663-1670.
48. 2 receptors in the rat hippocampus associated with kindling epileptogenesis. J. Neurochem. 70:1998;1615-1622.
49. Gobbi M., Monhemius R., Samanin R., Mennini T., Vezzani A. Cellular localization of neuropeptide-Y receptors in the rat hippocampus: long-term effects of limbic seizures. Neuroreport. 7:1996;1475-1480.
50. 2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113:1994;737-740.
51. Gregor P., Millham M.L., Feng Y., DeCarr L.B., McCaleb M.L., Cornfield L.J. Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family. FEBS Lett. 381:1996;58-62.
52. Gregor P., Feng Y., DeCarr L.B., Cornfield L.J., McCaleb M.L. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J. Biol. Chem. 271:1996;27776-27781.
53. Grundemar L., Jonas S.E., Morner N., Hogestatt E.D., Wahlestedt C., Hakanson R. Characterization of vascular neuropeptide Y receptors. Br. J. Pharmacol. 105:1992;45-50.
54. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA. 89:1992;5794-5798.
55. Hu Y., Bloomquist B.T., Cornfield L.J., DeCarr L.B., Flores-Riveros J.R., Friedman L., Jiang P., Lewis-Higgins L., Sadlowski Y., Schaefer J., Velazquez N., McCaleb M.L. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem. 271:1996;26315-26319.
56. Huh Y., Lee W., Cho J., Ahn H. Regional changes of NADPH-diaphorase and neuropeptide Y neurons in the cerebral cortex of aged Fischer 344 rats. Neurosci. Lett. 247:1998;79-82.
57. Huh Y., Kim C., Lee W., Kim J., Ahn H. Age-related change in the neuropeptide Y and NADPH-diaphorase-positive neurons in the cerebral cortex and striatum of aged rats. Neurosci. Lett. 223:1997;157-160.
58. Husum H., Mikkelsen J.D., Mork A. Extracellular levels of neuropeptide Y are markedly increased in the dorsal hippocampus of freely moving rats during kainic acid-induced seizures. Brain Res. 781:1998;351-354.
59. Inui A. Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharmacol. Sci. 20:1999;43-46.
60. 5 receptor gene in the human brain: an in situ hybridization study. Mol. Brain Res. 61:1998;100-107.
61. 1 receptor mRNA in the human brain: an in situ hybridization study. Neuroreport. 7:1996;1053-1056.
62. Jolicoeur F.B., Michaud J.N., Rivest R., Menard D., Gaudin D., Fournier A., St-Pierre S. Neurobehavioral profile of neuropeptide Y. Brain Res. Bull. 26:1991;265-268.
63. Jolicoeur F.B., Michaud J.N., Menard D., Fournier A. In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors. Brain Res. Bull. 26:1991;309-311.
64. Kalra S.P., Crowley W.R. Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front. Neuroendocrinol. 13:1992;1-46.
65. Kimmel J.R., Hayden L.J., Pollock H.G. Isolation and characterization of a new pancreatic polypeptide hormone. J. Biol. Chem. 250:1975;9369-9376.
66. Klapstein G.J., Colmers W.F. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 78:1997;1651-1661.
67. 1 receptors in kainic acid induced epilepsy in rats. Neurosci. Lett. 230:1997;129-132.
68. Kragh J., Tonder N., Finsen B.R., Zimmer J., Bolwig T.G. Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals. Exp. Brain Res. 98:1994;305-313.
69. 1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol. Pharmacol. 41:1992;817-821.
70. Larhammar D. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul. Pept. 62:1996;1-11.
71. Larhammar D. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul. Pept. 65:1996;165-174.
72. 1 type. J. Biol. Chem. 267:1992;10935-10938.
73. 2 receptor effects on natural meal patterns. Peptides. 12:1991;1251-1260.
74. Lundberg J.M., Hemsen A., Larsson O., Rudehill A., Saria A., Fredholm B.B. Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur. J. Pharmacol. 145:1988;21-29.
75. Lundberg J.M., Hemsen A., Rudehill A., Harfstrand A., Larsson O., Sollevi A., Saria A., Hokfelt T., Fuxe K., Fredholm B.B. Neuropeptide Y- and alpha-adrenergic receptors in pig spleen: localization, binding characteristics, cyclic AMP effects and functional responses in control and denervated animals. Neuroscience. 24:1988;659-672.
76. Lundell I., Statnick M.A., Johnson D., Schober D.A., Starback P., Gehlert D.R., Larhammar D. The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor. Proc. Natl. Acad. Sci. USA. 93:1996;5111-5115.
77. Lundell I., Blomqvist A.G., Berglund M.M., Schober D.A., Johnson D., Statnick M.A., Gadski R.A., Gehlert D.R., Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. 270:1995;29123-29128.
78. Malmstrom R.E., Hokfelt T., Bjorkman J.A., Nihlen C., Bystrom M., Ekstrand A.J., Lundberg J.M. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog. Regul. Pept. 75:1998;55-70.
79. Martel J.C., Alagar R., Robitaille Y., Quirion R. Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease. Brain Res. 519:1990;228-235.
80. Matsumoto M., Nomura T., Momose K., Ikeda Y., Kondou Y., Akiho H., Togami J., Kimura Y., Okada M., Yamaguchi T. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J. Biol. Chem. 271:1996;27217-27220.
81. McAuley M.A., Westfall T.C. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. J. Pharmacol. Exp. Ther. 261:1992;863-868.
82. McCullough L.A., Egan T.M., Westfall T.C. Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells. Am. J. Physiol. 274:1998;C1290-1297.
83. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI.International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50:1998;143-150.
84. Mikkelsen J.D., Woldbye D., Kragh J., Larsen P.J., Bolwig T.G. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Mol. Brain Res. 23:1994;317-322.
85. Munglani R., Hudspith M.J., Hunt S.P. The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive. Drugs. 52:1996;371-389.
86. 5 receptor. Soc. Neurosci. Abst. 25:1999;1350.
87. 5 receptor. Biochim. Biophys. Acta. 1328:1997;83-89.
88. Nakamura M., Aoki Y., Hirano D. Cloning and functional expression of a cDNA encoding a mouse type 2 neuropeptide Y receptor. Biochim. Biophys. Acta. 1284:1996;134-137.
89. 1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. J. Biol. Chem. 270:1995;30102-30110.
90. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, Academic Press, London, 1997.
91. Pickel V.M., Beck-Sickinger A.G., Chan J., Weiland H.A. Y1 receptors in the nucleus accumbens: ultrastructural localization and association with neuropeptide Y. J. Neurosci. Res. 52:1998;54-68.
92. 2+ entry. J. Neurosci. 17:1997;8169-8177.
93. R. Quirion, J.C. Martel, Neuropeptide Y receptors in mammalian brains, in: A. Bjorklund, T. Hokfelt, M.J. Kuhar (Eds), Handbook of Chemical Neuroanatomy, Elsevier, Amsterdam, 1992, pp. 247-287.
94. Quirion R., Martel J.C., Dumont Y., Cadieux A., Jolicoeur F., St-Pierre S., Fournier A. Neuropeptide Y receptors: autoradiographic distribution in the brain and structure-activity relationships. Ann. N.Y. Acad. Sci. 611:1990;58-72.
95. Rizzi M., Monno A., Samanin R., Sperk G., Vezzani A. Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur. J. Neurosci. 5:1993;1534-1538.
96. Roder C., Schwarzer C., Vezzani A., Gobbi M., Mennini T., Sperk G. Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience. 70:1996;47-55.
97. 1 receptor binding site, in: L. Grundemar, S.R. Bloom (Eds.), Neuropeptide Y and Drug Development, Academic Press, London, 1997, pp. 175-190.
98. Sadamatsu M., Kanai H., Masui A., Serikawa T., Yamada J., Sasa M., Kato N. Altered brain contents of neuropeptides in spontaneously epileptic rats (SER) and tremor rats with absence seizures. Life Sci. 57:1995;523-531.
99. 1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 368:1999;143-147.
100. 2, and pancreatic polypeptide receptors. Ann. N.Y. Acad. Sci. 611:1990;35-47.
101. 2 receptors in an animal model of temporal lobe epilepsy. Mol. Pharmacol. 53:1998;6-13.
102. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., Vezzani A. Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev. 22:1996;27-50.
103. Schwarzer C., Williamson J.M., Lothman E.W., Vezzani A., Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience. 69:1995;831-845.
104. 2 receptor. Regul. Pept. 75:1998;23-28.
105. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
106. Sperk G., Bellmann R., Gruber B., Greber S., Marksteiner J., Roder C., Rupp E. Neuropeptide Y expression in animal models of temporal lobe epilepsy. Epilepsy Res. Suppl. 12:1996;197-203.
107. Sperk G., Marksteiner J., Gruber B., Bellmann R., Mahata M., Ortler M. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience. 50:1992;831-846.
108. 1 receptor type be an autoreceptor?, Eur. J. Neurosci., submitted for publication.
109. 2 receptor. Br. J. Pharmacol. 123:1998;183-194.
110. St-Pierre J.A., Dumont Y., Quirion R. NPY-positive primary hippocampal cells bear NPY receptors: anatomical basis for an autoregulation. The Physiologist. 38:1995;A253.
111. 1 receptor mediating this peptide's effect. Peptides. 13:1992;581-587.
112. Takahashi Y., Sadamatsu M., Kanai H., Masui A., Amano S., Ihara N., Kato N. Changes of immunoreactive neuropeptide Y, somatostatin and corticotropin-releasing factor (CRF) in the brain of a novel epileptic mutant rat. Ihara's genetically epileptic rat (IGER). Brain Res. 776:1997;255-260.
113. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA. 79:1982;5485-5489.
114. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660.
115. Terenghi G., Polak J.M., Hamid Q., O'Brien E., Denny P., Legon S., Dixon J., Minth C.D., Palay S.L., Yasargil G. Localization of neuropeptide Y mRNA in neurons of human cerebral cortex by means of in situ hybridization with a complementary RNA probe. Proc. Natl. Acad. Sci. USA. 84:1987;7315-7318.
116. Terry R.D., Davies P. Dementia of the Alzheimer type. Annu. Rev. Neurosci. 3:1980;77-95.
117. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22:1999;25-30.
118. Vezzani A., Bendotti C., Rizzi M., Monno A., Tarizzo G., Samanin R. Functional activation of somatostatin and neuropeptide Y containing neurons in experimental models of limbic seizures. Epilepsy Res. Suppl. 12:1996;187-195.
119. Vezzani A., Monhemius R., Tutka P., Milani R., Samanin R. Functional activation of somatostatin- and neuropeptide Y-containing neurons in the entorhinal cortex of chronically epileptic rats. Neuroscience. 75:1996;551-557.
120. Vezzani A., Schwarzer C., Lothman E.W., Williamson J., Sperk G. Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res. 26:1996;267-279.
121. Wahlestedt C., Reis D.J. Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol. 33:1993;309-352.
122. Wahlestedt C., Blendy J.A., Kellar K.J., Heilig M., Widerlov E., Ekman R. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res. 507:1990;65-68.
123. Wahlestedt C., Yanaihara N., Hakanson R. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul. Pept. 13:1986;307-318.
124. Weinberg D.H., Sirinathsinghji D.J., Tan C.P., Shiao L.L., Morin N., Rigby M.R., Heavens R.H., Rapoport D.R., Bayne M.L., Cascieri M.A., Strader C.D., Linemeyer D.L., MacNeil D.J. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 271:1996;16435-16438.
125. Whittaker E., Vereker E., Lynch M.A. Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus. Brain Res. 827:1999;229-233.
126. 1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol. 125:1998;549-555.
127. 5-like receptors. Nature Med. 3:1997;761-764.
128. Woldbye D.P., Madsen T.M., Larsen P.J., Mikkelsen J.D., Bolwig T.G. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737:1996;162-168.
129. Zhang Z.J., Lappi D.A., Wrenn C.C., Milner T.A., Wiley R.G. Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons. Brain Res. 800:1998;198-206.